US EditionPublished • loading... • Updated
Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs
Summary by MedCity News
3 Articles
3 Articles
MedCity NewsReposted by 
Dealbreaker
DealbreakerWorldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs
The contract research organization consolidation trend continues with Worldwide Clinical Trials striking a deal for Catalyst Clinical Research, which has particular expertise in oncology. Worldwide is a portfolio company of Kohlberg, a private equity firm. The post Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs appeared first on MedCity News.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
